Histone deacetylase inhibition as an anticancer telomerase-targeting strategy
(2011)
Journal Article
Aberrant epigenetic regulation of gene expression contributes to tumor initiation and progression. Studies from a plethora of hematologic and solid tumors support the use of histone deacetylase inhibitors (HDACi) as potent anticancer agents. The mech... Read More about Histone deacetylase inhibition as an anticancer telomerase-targeting strategy.